TeneoBio Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 52

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.29B

  • Investors
  • 1

TeneoBio General Information

Description

Operator of a biotechnology company intended to develop biologics, human heavy-chain antibodies for the treatments of cancer, autoimmunity, and infectious diseases. The company's platform comprises genetically engineered animals, next-generation sequencing, bioinformatics, and throughput vector assembly technologies that rapidly identifies large numbers of unique binding molecules specific for therapeutic targets of interest, thereby enabling patients immune system to overcome diseases and disorders.

Contact Information

Website
www.teneobio.com
Formerly Known As
HCO Antibody
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 7999 Gateway Boulevard
  • Newark, CA 94560
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Amgen
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 7999 Gateway Boulevard
  • Newark, CA 94560
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TeneoBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 19-Oct-2021 $1.29B Completed Generating Revenue
3. Grant 24-Jul-2019 Completed Generating Revenue
2. Later Stage VC (Series A2) 08-Jan-2018 $10M $13.5M Completed Generating Revenue
1. Later Stage VC (Series A1) 03-May-2016 $3.5M $3.5M Completed Clinical Trials - General
To view TeneoBio’s complete valuation and funding history, request access »

TeneoBio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-2
Series A-1
To view TeneoBio’s complete cap table history, request access »

TeneoBio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biotechnology company intended to develop biologics, human heavy-chain antibodies for the treatments of ca
Biotechnology
Newark, CA
52 As of 2021

Haddonfield, NJ
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

TeneoBio Competitors (1)

One of TeneoBio’s competitors is Linnaeus Therapeutics, a Venture Capital-Backed company based in Haddonfield, NJ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Linnaeus Therapeutics Venture Capital-Backed Haddonfield, NJ
You’re viewing 1 of 1 competitors. Get the full list »

TeneoBio Patents

  • 154

    Total Documents Applications and Grants

  • Total Patents Families

  • 39

    Granted

  • 99

    Pending

  • Expiring in next 12 mo

TeneoBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2023312905-A1 Mesothelin binding proteins and uses thereof Pending 27-Jul-2022
US-20230192843-A1 Mesothelin binding proteins and uses thereof Pending 14-Oct-2021
AU-2022366971-A1 Mesothelin binding proteins and uses thereof Pending 14-Oct-2021
CA-3234966-A1 Mesothelin binding proteins and uses thereof Pending 14-Oct-2021
EP-4416186-A1 Mesothelin binding proteins and uses thereof Pending 14-Oct-2021 C07K16/30
To view TeneoBio’s complete patent history, request access »

TeneoBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TeneoBio Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Lightspeed Venture Partners Venture Capital Minority
Tesaro Corporation Minority
To view TeneoBio’s complete investors history, request access »

Ready to get started?

Request a free trial

TeneoBio FAQs

  • When was TeneoBio founded?

    TeneoBio was founded in 2009.

  • Where is TeneoBio headquartered?

    TeneoBio is headquartered in Newark, CA.

  • What is the size of TeneoBio?

    TeneoBio has 52 total employees.

  • What industry is TeneoBio in?

    TeneoBio’s primary industry is Biotechnology.

  • Is TeneoBio a private or public company?

    TeneoBio is a Private company.

  • What is the current valuation of TeneoBio?

    The current valuation of TeneoBio is .

  • What is TeneoBio’s current revenue?

    The current revenue for TeneoBio is .

  • How much funding has TeneoBio raised over time?

    TeneoBio has raised $13.5M.

  • Who are TeneoBio’s investors?

    Lightspeed Venture Partners and Tesaro have invested in TeneoBio.

  • Who are TeneoBio’s competitors?

    Linnaeus Therapeutics is a competitor of TeneoBio.

  • When was TeneoBio acquired?

    TeneoBio was acquired on 19-Oct-2021.

  • Who acquired TeneoBio?

    TeneoBio was acquired by Amgen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »